Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
about
Targeting the Eph System with Peptides and Peptide ConjugatesGeneral considerations on the biosafety of virus-derived vectors used in gene therapy and vaccinationThe Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of ObesityAdenovirus Early Proteins and Host SumoylationLiver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Gene Therapy 2017: Progress and Future Directions.Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency.The effect of interleukin 36 gene therapy in the regression of tumor.Novel adenovirus detected in captive bottlenose dolphins (Tursiops truncatus) suffering from self-limiting gastroenteritis.A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma.Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsCombined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.RNA interference in head and neck oncology.CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter.In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.Advances in Non-Viral DNA Vectors for Gene Therapy.Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.Assessment of Specificity of an Adenovirus Targeted to HER3/4.Fowl Adenovirus-Based Vaccine Platform.Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.Construction and characterization of recombinant human adenovirus type 5 expressing foot-and-mouth disease virus capsid proteins of Indian vaccine strain, O/IND/R2/75.State of play and clinical prospects of antibody gene transfer.Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation.Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.Gene therapy as a potential tool for treating neuroblastoma-a focused review.Endocytosis in gene therapy with non-viral vectors.Multivalent and Multipathogen Viral Vector Vaccines.Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma.Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested.Enzyme/Prodrug Systems for Cancer Gene Therapy.Chikungunya Virus Vaccines: Viral Vector-Based Approaches.Genetic Manipulation with Viral Vectors to Assess Metabolism and Adipose Tissue Function.CRISPR/Cas9: at the cutting edge of hepatology.Viral gene therapy for breast cancer: progress and challenges.Gene Delivery in Neuro-Oncology.Recombinant LCMV Vectors Induce Protective Immunity following Homologous and Heterologous Vaccinations.Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages.
P2860
Q26799461-EE2CC50A-AC6F-4CDA-9F5F-D44B25A4CD49Q26850701-A1F66374-5F8D-4BF6-9A5E-D5B846AEDAFEQ28067835-19440331-E0F9-4EEF-948C-040C77BE44D2Q28070074-2C23C899-D718-4FAC-B132-55B861D5879EQ30300575-402062A4-841C-4102-9CE0-16E6B5519156Q33635033-3E1DD8C0-09B7-4229-9FFF-28EBAB707793Q33881920-5D69F772-E39D-4E9F-BCE1-E20E9644E739Q33891559-1E49A7BB-87C9-4DFA-BC0B-CC9A8BDF211CQ33914097-18888D22-3CA7-456F-874C-9C9161EF9B27Q35015898-380447A1-0AA6-48CD-856C-044393BCE648Q35608449-A5DE1B95-ABEC-40A0-9871-DD1F9A20D6C1Q35658592-12DE3E5F-2F4F-46BD-9938-F74B2886362BQ35826779-157C5D60-FD50-4F86-9D25-2622CF04DCA2Q36879787-6C91B2EE-56D4-4BE8-A760-6FFCA2ECAE5AQ37035972-38E2CAC6-E4A8-4DDF-8B15-9D56D2276D98Q37406819-36F3B67E-5441-4CEB-B52D-CA9948FADE89Q37420781-355FDCDB-DC50-4C75-BB54-1E93D804FC63Q37631284-AE359B53-84C4-44C8-BDD0-149766FDE8FDQ37676243-D9B1FE13-D6B0-4FA9-8610-5D6DA8436A51Q38286386-1AFFE31C-030B-4DA2-9B4E-A1C9AB044F6FQ38645041-03F5F374-C774-4C9D-B844-78DAA2C31E56Q38709028-1104E843-7C7D-47C5-A79F-E56EB5D339F4Q38712002-E7AB68CD-7314-446F-9C8F-7C7B2991923DQ38722608-D56A8DAC-02CB-4E67-8477-962AC063BE0AQ38737706-21CA0D5C-FCC0-4B41-A661-3D1E4557D517Q38756454-E22B3648-96CF-4B2B-82E3-7F71D9E7D4ADQ38804304-AA57A08A-6E44-4618-8407-421122C4F83EQ38808728-56C08256-072C-41D8-A8B5-49C1F7E7C7D5Q38824421-964F7DA6-6F38-4092-BB16-A2764EC61E7CQ38830323-A7A8359A-BDD9-4886-BA1A-819093A73376Q38835086-CE8B02E6-B2FC-4980-A2F7-B241C57D3465Q38849248-43DE08A0-4677-4D3F-9C82-2552E9F2CA55Q39064497-68A9296F-6137-4ABC-8A7A-F6AB31C55ED6Q39128566-9EDDA08D-79DB-4B08-BFD9-6A583A0E9EE0Q39154081-DBDD4593-B17A-4897-9E43-5F987CDE2772Q39294371-FE48FF59-4E90-4957-B7B5-3FC1E628CBF3Q39366114-2D1BB92A-171C-4FF6-ABD2-35076F015AAAQ40060078-EF648B6C-E5BB-4E15-8D71-D15FAB6AE04FQ40084604-47F27369-97EF-4EA0-8657-600EA9B5C767Q40098925-222FAD15-019C-4705-9EE1-61BA2A137423
P2860
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@ast
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@en
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@nl
type
label
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@ast
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@en
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@nl
prefLabel
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@ast
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@en
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@nl
P2860
P3181
P1433
P1476
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
@en
P2093
William S M Wold
P2860
P304
P3181
P356
10.2174/1566523213666131125095046
P407
P50
P577
2013-12-01T00:00:00Z